腾讯控股(00700):游戏业务稳中有升,AI带动广告强劲增长
Huaan Securities· 2025-11-26 07:57
Investment Rating - The investment rating for Tencent Holdings is "Buy" (maintained) [1] Core Views - Tencent's Q3 revenue reached 192.87 billion yuan, representing a year-over-year increase of 15% and a quarter-over-quarter increase of 5%, exceeding consensus expectations of 188.8 billion yuan [4] - The adjusted net profit for Q3 was 70.55 billion yuan, up 18% year-over-year and 12% quarter-over-quarter, surpassing the consensus estimate of 65.97 billion yuan [4] - The growth in revenue and profit is driven by strong performance in the gaming sector, robust advertising growth fueled by AI, and improvements in financial technology services [4][10] Summary by Sections Q3 Performance - Revenue: 192.87 billion yuan (yoy +15%, qoq +5%), above consensus of 188.8 billion yuan [4] - Gross Profit: 108.8 billion yuan (yoy +22%, qoq +4%), exceeding consensus of 106.39 billion yuan [4] - Adjusted Net Profit: 70.55 billion yuan (yoy +18%, qoq +12%), above consensus of 65.97 billion yuan [4] Value-Added Services (VAS) - Domestic game revenue reached 42.8 billion yuan (yoy +15%), driven by stable contributions from titles like "Delta Action" and "Honor of Kings" [5] - International game revenue was 20.8 billion yuan (yoy +43%), exceeding expectations due to growth from Supercell games and new releases [5] Marketing Business - Marketing revenue was 36.2 billion yuan (yoy +21%), surpassing expectations, driven by AI-enhanced advertising platforms [6] - The combined MAU for WeChat reached 1.414 billion, a year-over-year increase of 2% [6] Financial Technology - Financial technology revenue was 58.2 billion yuan (yoy +10%), supported by growth in commercial payment activities and consumer loan services [7] AI Investments - Capital expenditure for Q3 was 12.98 billion yuan, a year-over-year decrease of 24% [8] - AI capabilities are continuously improving, with advancements in transaction ecosystems and model performance [8][9] Investment Recommendations - Projected net profits for 2025, 2026, and 2027 are 257.02 billion yuan, 290.51 billion yuan, and 319.01 billion yuan respectively, with stable growth expected in gaming and advertising sectors [10]
周大福(01929):FY2026H1经营表现稳健,期待下半财年复苏表现
GOLDEN SUN SECURITIES· 2025-11-26 07:57
公司 FY2026H1 营收同比下降 1.1%,经营利润同比增长 0.7%,经营 表现稳步改善。公司披露 FY2026H1 中报,公司营收同比下降 1.1%至 389.86 亿港元,与此同时受益于产品结构优化以及公司良好的费用管控, 经营利润率同比提升 0.3pcts 至 17.5%,经营利润同比增长 0.7%至 68.23 亿港元,呈现稳步复苏的态势,综合考虑黄金借贷公允价值变动的影响后, 归母净利润同比增长 0.1%至 25.34 亿港元。公司派发中期股息每股 0.22 港元,派息率 85.7%。 证券研究报告 | 半年报点评 gszqdatemark 2025 11 26 年 月 日 周大福(01929.HK) FY2026H1 经营表现稳健,期待下半财年复苏表现 内地:FY2026H1 内地营收下降 2.5%,公司持续优化渠道网络。 FY2026H1 中国内地营收同比下降 2.5%至 321.94 亿港元,其中零售/批 发渠道营收同比+8.1%/-10.2%,门店整合导致批发业务营收下降。 ➢ 渠道端:FY2026H1 线下聚焦单店运营优化门店,电商增速亮眼。 截止期末公司于中国内地拥有 5663 家 ...
周大福(01929):上半财年整体业绩稳定,十月以来同店销售加速增长
Guoxin Securities· 2025-11-26 07:33
Investment Rating - The investment rating for Chow Tai Fook (01929.HK) is "Outperform the Market" [7] Core Views - The overall performance for the first half of the fiscal year is stable, with accelerated growth since October. For the first half of fiscal year 2026 (April 2025 - September 2025), the company achieved revenue of HKD 38.986 billion, a slight decline of 1.1% year-on-year, impacted by store strategy contraction and high gold prices affecting product weight. The net profit attributable to shareholders was HKD 2.534 billion, a slight increase of 0.13%, maintaining overall stability. Since October, the company has seen further acceleration in growth, with retail value increasing by 33.9% year-on-year from October 1 to November 18, and same-store sales in mainland China growing by 38.8% [1][4] Summary by Sections Revenue and Profitability - The retail revenue in mainland China increased by 8.1%, accounting for 38.4% of total revenue. Wholesale revenue in mainland China decreased by 10.2%, making up 44.2% of total revenue due to overall store contraction and reduced purchasing under high gold prices. Revenue from Hong Kong, Macau, and overseas markets grew by 6.5%, accounting for 17.4% of total revenue. The revenue from priced jewelry increased by 9.3%, representing 29.6% of total revenue, with priced gold performing particularly well [2] Cost Management and Margins - The overall gross margin remained above 30%, at 30.5%, a decrease of 0.9 percentage points year-on-year, primarily due to a reduced increase in gold prices compared to the same period last year. The increase in the proportion of priced products positively impacted the gross margin. The selling and administrative expense ratio decreased by 1.2 percentage points to 14%, benefiting from cost control optimization. Inventory turnover days shortened by 33 days to 424 days [3] Future Outlook and Adjustments - The company plans to further enhance the layout of high-margin priced products and optimize store structure to boost same-store sales. Given the 32.4% increase in London gold prices since the beginning of fiscal year 2026, which is 7.4 percentage points lower than the previous fiscal year's increase of 39.8%, the expected fair value loss on gold loans has been adjusted higher. Consequently, the net profit forecasts for fiscal years 2026-2028 have been revised down to HKD 7.141 billion, HKD 8.178 billion, and HKD 9.061 billion, respectively, with corresponding P/E ratios of 21.1, 18.4, and 16.6 [4][5]
绿城管理控股(09979):行业竞争趋于理性,经营筑底分红较高
Ping An Securities· 2025-11-26 07:14
房地产 2025 年 11 月 26 日 绿城管理控股(9979.HK) 行业竞争趋于理性,经营筑底分红较高 推荐(维持) 股价:3.12 港元 主要数据 | 行业 | 房地产 | | --- | --- | | 公司网址 | www.lcgljt.com | | 大股东/持股 | 绿城中国/71.63% | | 实际控制人 | 国务院国有资产监督管理委员会 | | 总股本(百万股) | 2000.00 | | 流通 A 股(百万股) | 0 | | 流通 B/H 股(百万股) | 2000.00 | | 总市值(亿港元) | 62.4 | | 流通 A 股市值(亿元) | 0 | | 每股净资产(元) | 1.79 | | 资产负债率(%) | 45.41 | 行情走势图 相关研究报告 【平安证券】绿城管理控股(9979.HK)*半年报点评* 竞争加剧致业绩承压,回归理性增长*推荐20250825 【平安证券】绿城管理控股(9979.HK)*年报点评*规 模领先,竞争加剧*推荐20250331 证券分析师 | 杨侃 | 投资咨询资格编号 | | --- | --- | | | S1060514080002 ...
周大福(01929):FY26H1稳健修复,持续关注产品与渠道升级
CMS· 2025-11-26 07:13
Investment Rating - The report maintains a "Strong Buy" rating for Chow Tai Fook [2][7] Core Views - Chow Tai Fook's FY26H1 revenue decreased by 1.1% year-on-year, while net profit increased by 0.1%. The company declared an interim dividend of HKD 0.22 per share, with a payout ratio of 85.7% [6][7] - Strong terminal growth was observed from October 1 to November 18, with same-store sales in mainland China increasing by 38.8%, driven by a 93.9% increase in priced jewelry and a 23.0% increase in gold jewelry [6][7] - The company is expected to benefit from rising gold prices in the second half of the fiscal year, leading to an upward revision of profit forecasts for FY2026 to FY2028 [7] Financial Performance Summary - FY26H1 revenue was HKD 389.9 billion, with a breakdown showing mainland China revenue at HKD 321.9 billion (down 2.5%) and Hong Kong, Macau, and other markets at HKD 67.9 billion (up 6.5%) [6] - The company closed 611 underperforming stores while opening 8 new flagship stores, focusing on enhancing store quality and optimizing the retail network [6] - The gross margin for FY26H1 was 30.5%, with a slight year-on-year decrease of 0.9 percentage points, while operating profit margin reached a five-year high of 17.5% [6][7] Earnings Forecast and Valuation - Revenue projections for FY2026 to FY2028 are HKD 94.001 billion, HKD 98.800 billion, and HKD 104.748 billion, respectively, with net profit estimates of HKD 8.707 billion, HKD 9.804 billion, and HKD 10.864 billion [7][8] - The current market capitalization corresponds to a FY26 PE ratio of 17.5X, indicating a favorable valuation [7][8]
阿里巴巴-W(09988):AI云业务持续高增速,后续关注及时零售亏损减少
CSC SECURITIES (HK) LTD· 2025-11-26 06:32
Investment Rating - The report maintains a "Buy" rating for the company, with a target price of HK$ 180 [1][6]. Core Insights - The company reported FY2026 Q2 revenue of RMB 247.8 billion, a year-on-year increase of 5%. Excluding disposed businesses, the revenue growth was 15%. Operating profit decreased by 85% to RMB 5.4 billion, while net profit attributable to shareholders fell by 53% to RMB 21 billion, aligning with market expectations [7]. - The core e-commerce business remains stable, with customer management revenue increasing by 10% to RMB 78.9 billion, driven by the improved penetration of the service fee model and a significant rise in monthly active consumers on the Taobao app [9]. - The timely retail business experienced rapid growth, with revenue up 60%, and losses are expected to decrease in line with market forecasts [9]. - Cloud business revenue exceeded market expectations, reaching RMB 39.8 billion, a 34% year-on-year increase, primarily due to growth in public cloud services and increased adoption of AI-related products [9]. - Capital expenditures remain high at RMB 31.4 billion, with a potential increase in the three-year total spending guidance to RMB 380 billion, reflecting continued strong investment in AI [9]. Summary by Sections Financial Performance - For FY2026, the company is projected to achieve a net profit of RMB 116.3 billion, a decrease of 10.6% year-on-year, with EPS of RMB 6.12, corresponding to a P/E ratio of 23.58 [11]. - The company’s net profit for FY2024 and FY2025 is expected to be RMB 80.0 billion and RMB 130.1 billion, respectively, with significant growth in FY2025 [11]. Market Position - The company holds a market capitalization of HK$ 175.3 billion, with a share price of HK$ 157.80 as of November 25, 2025 [2]. - The stock has shown a significant increase of 85.92% over the past month, although it has decreased by 9.10% over the past year [2]. Shareholder Information - Major shareholders include JPMorgan Chase & Co., holding 3.57% of the shares [2].
同程旅行(00780):稳健增长符合预期
HTSC· 2025-11-26 06:07
证券研究报告 港股通 2025 年 11 月 26 日│中国香港 互联网 同程公布 3Q25 业绩:收入 55 亿元,yoy+10.4%,基本符合 VA 一致预期 (简称预期)的 54.9 亿元;经营利润 11.6 亿元,超预期 7.5%,经营利润 率持续优化,yoy+1.5pct,主要来自于精细化补贴和费用管控;调整后净利 润 10.6 亿元,超预期 2.8%。公司本季度收入表现基本符合预期,利润超预 期。我们看好国内旅游的需求韧性,同时公司高品质酒店占比提升,带来结 构性改善。维持"买入"评级。 公司收入基本符合预期,酒店/机票价格改善贡献正向驱动 公司 3Q25 收入 55 亿元,yoy+10.4%,基本符合预期。拆分来看,核心 OTA 业务中,住宿及预定服务收入达 15.8 亿元,yoy+14.7%,基本符合预期。 暑期旅游旺季需求释放,同时公司高品质酒店预订占比提升,客房量增长超 20%,而酒店价格止跌回正,成为收入增长正向驱动。交通业务持续稳健增 长,收入 22.09 亿元,yoy+9.0%,主要源于用户的需求增加以及持续丰富 的增值产品及服务,且机票票价止跌,我们预计未来交通业务量将保持稳健 增 ...
阿里巴巴-W(09988):云收入延续加速增长且闪购减亏在轨
HTSC· 2025-11-26 06:06
证券研究报告 阿里巴巴-W (9988 HK/BABA US) 港股通 云收入延续加速增长且闪购减亏在轨 华泰研究 中报点评 2025 年 11 月 26 日│中国香港/美国 互联网 阿里巴巴 2QFY26 总收入 2,478 亿元,同增 4.8%,好于 VA 一致预期(下同) /华泰预测的同增 2.2/2.9%,主因云业务增速超预期;经调整 EBITA 为 91 亿 元,同比-77.6%,经调整 EBITA 利润率 3.7%,逊于一致预期的 5.3%但好于 华泰预测的 3.2%。管理层在 2QFY26 业绩会上表示公司持续投入于全栈 AI 能力建设,且 AI 与阿里生态的协同效应带来了更大的发展空间,并在消费领 域继续推动各业务深度协同,大消费平台的效应已初步显现。展望后续,管 理层表示将继续投入 AI+云业务以产生更强的协同效应。我们预计随着模型实 力逐步增强和国内 AI 需求的持续增长,阿里有望以千问 APP 为中心,与阿 里旗下其它业务线如淘宝、高德、闪购和支付宝等进一步联通,帮助阿里在 ToC 端的 AI 流量入口处强化竞争力。闪购业务的持续减亏或有望为公司的中 短期利润额修复斜率提供一定支持。建议 ...
先瑞达医疗-B(06669):深耕介入无植入,技术平台打造核心竞争力
Guotou Securities· 2025-11-26 03:20
Investment Rating - The report assigns a "Buy-A" investment rating with a target price of 15 HKD over the next six months, reflecting a dynamic P/E ratio of 21 times for 2026 [4][6]. Core Insights - The company focuses on "interventional non-implant" treatment, utilizing drug-coated balloons (DCB) to expand narrowed blood vessels without leaving permanent implants, thus avoiding related complications and preserving future treatment options [1][19]. - Recent domestic procurement policies are expected to ease, and new products are entering a growth phase, with the company's core products included in the procurement scope [2][39]. - The partnership with Boston Scientific is anticipated to accelerate the company's international expansion, with several products already approved in the U.S. [3][38]. Summary by Sections Company Overview - The company, established in 2011, specializes in "interventional non-implant" treatment solutions for various vascular diseases and has developed several leading medical devices [15]. - The company has a strong management team with extensive experience in the medical device industry [16][17]. Product and Technology - The company has developed a comprehensive range of DCB products for multiple indications, including above-knee, below-knee, coronary, and arteriovenous fistula stenosis [22][26]. - The technology platforms include drug coating technology, aspiration platform technology, radiofrequency ablation technology, and materials technology, which enhance product functionality and reduce production costs [28][29]. Market Dynamics - The domestic procurement policy is set to ease, with the sixth batch of high-value consumables procurement rules expected to optimize the bidding process [2][39]. - The DCB market in China is projected to grow significantly, from over 1 billion CNY in 2019 to 14.2 billion CNY by 2030 [22]. Financial Projections - Revenue growth is expected to be 19.99%, 21.99%, and 29.05% from 2025 to 2027, with net profit growth of 130.43%, 66.62%, and 73.46% during the same period [4][9].
阿里巴巴-W(09988):FY26Q2财报点评:电商收入及利润增势稳健,云业务加速增长
CMS· 2025-11-26 03:04
Investment Rating - The report maintains a "Strong Buy" rating for Alibaba Group [3][5] Core Insights - Alibaba's revenue for FY2026Q2 reached 247.8 billion yuan, a 5% increase year-on-year, while Non-GAAP net profit was 10.4 billion yuan, down 72% [1] - The e-commerce segment shows steady growth in monetization rates, with a stable market share in food delivery and potential for improvement in profitability [1][5] - The cloud business exceeded expectations with significant revenue growth driven by strong demand in the AI cloud market, indicating a promising outlook for future growth [1][5] Financial Data Summary - **Revenue Forecasts**: Projected revenues for FY2024 to FY2028 are 941.2 billion yuan, 996.3 billion yuan, 1,062.5 billion yuan, 1,168.7 billion yuan, and 1,285.6 billion yuan respectively, with year-on-year growth rates of 8%, 6%, 7%, 10%, and 10% [2][8] - **Adjusted EBITA**: Expected adjusted EBITA for FY2026 is 117.2 billion yuan, reflecting a significant decrease of 32% compared to FY2025 [2][8] - **Non-GAAP Net Profit**: Forecasted Non-GAAP net profits for FY2026 to FY2028 are 106.9 billion yuan, 166.6 billion yuan, and 201.8 billion yuan respectively, with a notable decline of 32% in FY2026 [2][8] - **Earnings Per Share (EPS)**: EPS is projected to be 5.63 yuan for FY2026, with a PE ratio of 25.5 [2][9] Stock Performance - The stock has shown an absolute performance of 20% over the past 12 months, with a relative performance of -9.8% [4] Valuation - The target price is set at 185 HKD per share, with the current stock price at 158 HKD, indicating potential upside [3][5]